VIP: what it is and what the evidence says
Vasoactive intestinal peptide; studied for its relationship with immune modulation, inflammation and vascular function.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
The immune system is not something you turn "up" or "down": it is regulated. A compound that raised the response without control would be a problem, not a benefit, which is why the correct word is modulation. For people with autoimmune or inflammatory conditions, this stops being a technical nuance.
What it is studied for
Immune balance, inflammation modulation.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
Synthetic VIP (aviptadil) has been tested in real randomized trials in COVID-19 respiratory failure and in an inhaled study in sarcoidosis, with mostly negative results.
The limitation that matters most
The large, well-controlled TESICO trial (2023) showed no benefit, and the half-life of VIP is barely minutes, which limits any use outside hospital infusion or inhalation.
Regulatory status
Not approved.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Use and research in specific contexts; variable individual response.
With immune, cardiovascular or respiratory conditions, prioritize professional assessment.
What this page cannot give you
A reference page can take you this far. You know what VIP is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialhuman Lancet Respir Med · 2023 · PMID 37348524 →
- The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trialhuman Crit Care Med · 2022 · PMID 36044317 →
- Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosishuman Am J Respir Crit Care Med · 2010 · PMID 20442436 →
- Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis Indian J Crit Care Med · 2025 · PMID 41368449 →
- Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeuticsreview Hippokratia · 2013 · PMID 23935337 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for VIP or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is VIP?
Vasoactive intestinal peptide; studied for its relationship with immune modulation, inflammation and vascular function. It is studied within the area of immune.
Is there human evidence for VIP?
Synthetic VIP (aviptadil) has been tested in real randomized trials in COVID-19 respiratory failure and in an inhaled study in sarcoidosis, with mostly negative results.
Is it approved by any health agency?
Not approved.
What is the dose of VIP?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what VIP is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.